共 22 条
- [1] Baseline characteristics of refractory CSU patients from the UK: data from A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation study (AWARE) CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (12): : 1639 - 1639
- [2] A Comparison of Treatment Patterns in chronic spontaneous Urticaria and Baseline Characteristics of the German AWARE Study: Hospital versus established Dermatologist JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 92 - 92
- [4] Chronic Spontaneous Urticaria in elderly Patients: Patient Characteristics, Comorbidities and Treatment Patterns, Results of the German AWARE Study JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 72 - 73
- [7] Evaluation of antihistamine-refractory chronic urticaria patients who used biological agent treatment in terms of cardiovascular risk POSTEPY DERMATOLOGII I ALERGOLOGII, 2024, 41 (06): : 610 - 616
- [8] ASSURE-CSU: Preliminary Results from Germany; An Analysis of the Diagnosis and Treatment of Patients with Antihistamine-refractory Chronic spontaneous Urticaria (CSU) JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 121 - 122
- [10] Real-world evidence from the AWARE study in Germany highlights the need for greater awareness of guideline recommendations for the treatment of patients with H1-antihistamine-refractory chronic spontaneous urticaria JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 114 - 114